June Is Cancer Immunotherapy Month
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
Category: Meetings
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
Conference co-chair Elaine R. Mardis, PhD, discusses the third conference in the AACR's Precision Medicine Series, “Integrating Clinical Genomics...
May is Brain Cancer Awareness Month, and this week, the sharpest minds in brain cancer research will convene in...
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
During the American Association for Cancer Research Annual Meeting held last month in Philadelphia, 30 patient advocates—many of them...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The...
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
Hear from AACR President Carlos L. Arteaga, MD, and Annual Meeting Program Committee Chairperson Lewis C. Cantley, PhD, about...
With the start of the AACR Annual Meeting 2015 only four days away, the organization is ramping up its...